Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Clin Auton Res. 2019 Feb 19;29(4):469–473. doi: 10.1007/s10286-019-00593-0

Quantitative Magnetic Resonance Evaluation of the Trigeminal Nerve in Familial Dysautonomia

Eugene Won 1, Jose-Alberto Palma 2, Horacio Kaufmann 2, Sarah S Milla 1,3, Benjamin Cohen 1, Lucy Norcliffe-Kaufmann 3, James S Babb 1, Yvonne W Lui 1
PMCID: PMC6697601  NIHMSID: NIHMS1522176  PMID: 30783821

Abstract

Purpose:

Familial dysautonomia (FD) is a rare autosomal recessive disease that affects development of sensory and autonomic neurons, including those in the cranial nerves. We aimed to determine whether conventional brain magnetic resonance imaging (MRI) could detect morphologic changes in the trigeminal nerves of these patients.

Methods:

Cross-sectional analysis of brain MRI of patients with genetically confirmed FD and age- and sex-matched controls. High-resolution 3D gradient echo T1-weighted sequences were used to obtain measurements of the cisternal segment of the trigeminal nerves. Measurements were obtained using a two-reader consensus.

Results:

Twenty pairs of trigeminal nerves were assessed in 10 patients with FD and 10 matched controls. Median (interquartile range) cross-sectional area of the trigeminal nerves in patients with FD was 3.5 (2.1) mm2 compared to 5.9 (2.0) mm2 in controls (P<0.001). No association between trigeminal nerve area and age was found in patients or controls

Conclusions:

Using conventional MRI, the caliber of the trigeminal nerves was significantly reduced bilaterally in patients with FD compared to controls, a finding that appears to be highly characteristic of this disorder. The lack of correlation between age and trigeminal nerve size supports arrested neuronal development, rather than progressive atrophy.

Keywords: Hereditary sensory autonomic neuropathy, Neuroimaging, Autonomic dysfunction, Riley-Day syndrome, Neuroimaging, Trigeminal nerve

INTRODUCTION

Familial dysautonomia (FD), also known as Riley-Day syndrome or hereditary sensory and autonomic neuropathy type III, is a rare autosomal recessive disease, caused by a founder mutation of the IKBKAP gene on chromosome 9q31, which encodes for the elongator-1 protein (ELP-1, also known as I-k B kinase-associated protein or IKAP) [17]. The deficiency of ELP-1 during embryogenesis affects the development of autonomic and sensory neurons with cell bodies in the dorsal root and cranial nerve ganglia [6, 9, 22].

Hallmark features of the disease are reduced pain and temperature perception, absent corneal reflexes [7, 12], reduced basal lacrimation [16], and neurogenic dysphagia [2, 5, 18, 19]. These are all functions that rely on sensory feedback from trigeminal nerve afferents, and activities such as chewing [15], swallowing [13, 19] and speech [8] remain abnormal throughout life for these patients. Moreover, reduced facial sensation can result in oral and facial trauma and self-mutilation [14].

Post-mortem neuropathological studies in patients with FD reveal marked reduction in size and number of sensory neurons arising from the Gasserian ganglia as well as absence of myelin sheaths along the mesencephalic tract [3, 20]. There is, however, limited literature on in vivo neuroimaging evaluation of patients with FD. Focusing on a major afferent pathway involved in FD, we used MRI to assess whether the caliber of trigeminal nerves is reduced compared to age- and sex-matched controls. We hypothesized that the caliber of the trigeminal nerve is reduced in these patients compared to controls. Small trigeminal nerves could potentially constitute a novel neuroimaging marker of this disorder.

METHODS

Design and participant selection

This was a single-center cross-sectional study including patients with genetically confirmed FD who had a neurological clinical assessment and a brain MR imaging at our institution over an 8-year period (2003–2011). A comprehensive review of their clinical chart was performed, with attention to clinical features of trigeminal dysfunction, including decreased corneal sensation, decreased lacrimation, and neurogenic dysphagia. Age- and sex-matched control patients were identified by searching consecutively performed brain MRI exams of subjects undergoing routine evaluation for the indication of “headache” who were found to have normal MRI examination. All MRI images were anonymized and randomized for review. The New York University Institutional Review Board approved this study.

Neuroimaging

The cross-sectional area of the cisternal portion of the trigeminal nerves was measured bilaterally in all subjects using standard T1-weighted magnetization-prepared rapid acquisition gradient echo (MPRAGE) images acquired in the axial plane (Sonata 1.5-Tesla, inversion time (TI) 1100, repetition time (TR) 2100, echo time (TE) 3.67, flip angle (FA) 7, field of view (FoV) 220×220, matrix size 256×218). Source data centered at the level of the cisternal trigeminal nerve were used to prescribe 1-mm double-oblique reconstructions oriented perpendicular to the long axis of the nerve (Figure 1). Region of interest (ROI) measurement was done on the cisternal slice demonstrating the largest nerve cross sectional area and placed by two reviewer consensus blinded to subject group.

Figure 1. Trigeminal nerve neuroimaging in familial dysautonomia and controls.

Figure 1.

Double oblique orthogonal reconstructions from 3D MPRAGE images through the cisternal left trigeminal nerve in a 27-year old patient with familial dysautonomia (A, B) and an age- and sex-matched control (C, D). Note the considerably smaller caliber of the left trigeminal nerve (arrows) in the patient with familial dysautonomia.

Statistics

A nonparametric Wilcoxon signed rank test was used to compare the subject groups in terms of nerve caliber on the left and right sides and the within-subject average over sides. Partial Spearman Rank correlation characterized the association between nerve caliber and age while controlling for study group. In an attempt to study the association between trigeminal nerve caliber and clinical severity, we quantified the degree of neurotrophic keratopathy (the corneal afferent information is conveyed by the trigeminal nerve) using the Mackie classification ranging from 0 (no corneal damage) to 3 (severe corneal ulcers) [11].

Receiver operating characteristic (ROC) curves for the mean, minimum, and maximum measurements of left and right trigeminal nerves were calculated to identify cut-off values of trigeminal caliber to distinguish between patients with FD and controls. All statistical tests were conducted at the two-sided 5% significance level using MedCalc version 17.9.7 (MedCalc Software, Ostend, Belgium).

RESULTS

Twenty pairs of nerves from 10 patients with FD (7 women, aged 8–61 years old) and 10 aged- and sex-matched controls were studied. The body mass index at the time of neuroimaging acquisition was similar in FD and controls (23.3±2.8 in FD vs. 25.1±4.5 kg/m2 in controls; P=0.28). All patients with FD had clinical evidence of impaired afferent trigeminal function including diminished corneal reflexes with keratopathy, reduced basal lacrimation, and neurogenic dysphagia. The cross-sectional area of the trigeminal nerve in patients with FD was 3.5±2.1 mm2 vs. 5.9±2.0 mm2 in the control group (median ± interquartile range, P=0.002) (Figure 1) Significant differences were also seen between patients and controls when analyzing the left and right nerve subgroups separately: on the left, 3.0±2.1 mm2 compared to 6.0±1.6 mm2 (FD vs. controls, P=0.0059), and on the right, 4.2±1.4 mm2 vs. 5.8±3.4 mm2 (FD vs. controls, P=0.0039) respectively (Figure 1). There was no association between trigeminal caliber and age while controlling for study cohort (ρ=0.09, P=0.72).

The neurotrophic keratitis stage of patients with FD ranged from 1 to 3. Higher scores were significantly associated with smaller areas of the right side (ρ=−0.72, P=0.017), and the average (ρ=−0.72, P=0.018) trigeminal nerve. Higher scores tended to be associated with smaller areas of the left trigeminal nerve, although this did not reach statistical significance (ρ=−0.48, P=0.15).

ROC curves for the mean, minimum, and maximum trigeminal cross-sectional areas had an area under the curve (AUC) value of 0.99 (95% confidence interval (CI) 0.81 to 1.0), 0.97 (95% CI 0.78 to 1.0), and 0.97 (95% CI 0.78 to 1.0), respectively. A cross-sectional area ≤ 4.85 mm2 had 100% sensitivity and 90% specificity, and area ≤ 4.42 mm2 had 90% sensitivity and 100% specificity to distinguish between FD and controls.

DISCUSSION

This study shows that the cross-sectional area of the cisternal trigeminal nerve as measured on routine MRI was significantly smaller in patients with FD compared to age- and sex-matched normal controls bilaterally. Reduced trigeminal caliber bilaterally appears to be a highly characteristic finding of FD, although validation in larger samples might be required. This is not surprising, as the disorder is characterized by impaired development of sensory (afferent) neurons resulting in sensory and autonomic deficits. Our results provide objective in vivo evidence supporting neuropathological findings of reduced number of sensory neurons in the trigeminal ganglia in a few patients with FD. [3, 20, 21]

Trigeminal nerve atrophy follows trigeminal nerve injury, compression, or denervation, but the findings in these scenarios are typically unilateral. Here, we found reduced caliber on both sides, an imaging finding which may be highly characteristic of FD.

The lack of correlation between age and nerve size argues against progressive atrophy and instead supports the theory of arrested afferent neural development of the trigeminal nerve, in keeping with current thinking regarding the pathophysiology of the disorder. This suggests that trigeminal imaging might not be a suitable outcome measure for clinical trials of disease modification in FD. The association between higher degree of corneal damage and lower trigeminal area in the right and the average support the hypothesis that lack of trigeminal afferences contribute to lack of corneal sensitivity in patients with FD. There was also a similar trend with the left trigeminal area, although the lack of statistical significance might be due to the small sample size.

Limitations of the study include its retrospective nature and small sample size. However, FD is an extremely rare disease with an incidence among Ashkenazi Jews estimated at 1:10,000 in North America [4] and 1 in 3,700 in Israel [10]. Moreover, there is only one previous neuroimaging study in patients with FD, which enrolled 7 patients [1]. Our cohort of 10 well-characterized, genetically confirmed, patients with FD with imaging data is a sizable group for this uncommon disorder and showed a strong statistically significant differences compared to controls. Further studies should quantify the diameter of other cranial nerves with predominantly motor function (e.g., cranial nerves III, IV, VI or XII). Normal caliber of motor cranial nerves would support the notion of FD as a disorder predominantly affecting the development of sensory (afferent) nerves. Advanced cranial nerve evaluation requires specific MR sequences not typically used in standard protocols [23].

In conclusion, the trigeminal nerve is significantly smaller in patients with FD compared to age- and sex-matched controls. The findings are consistent with clinical neurologic deficits as well as pathologic studies showing reduced number of trigeminal ganglion neurons in patients with FD. [3, 7, 20, 21] Bilateral reduced caliber of the cisternal trigeminal nerve appears to be a characteristic imaging feature of FD.

Figure 2. Trigeminal nerve area in familial dysautonomia and controls.

Figure 2.

Patients with familial dysautonomia had significantly reduced area in both right and left trigeminal nerves, as well as the average of both sides.

Funding source:

National Institutes of Health (U54-NS065736–01) and Familial Dysautonomia Foundation, Inc.

Conflict of interests:

Dr. Palma receives funding support from the Familial Dysautonomia Foundation and is Managing Editor of Clinical Autonomic Research.

Dr. Norcliffe-Kaufmann receives funding support from the Familial Dysautonomia Foundation. Dr. Kaufmann receives funding support from the Familial Dysautonomia Foundation and is Editor in Chief of Clinical Autonomic Research.

REFERENCES

  • 1.Axelrod FB, Hilz MJ, Berlin D, Yau PL, Javier D, Sweat V, Bruehl H, Convit A (2010) Neuroimaging supports central pathology in familial dysautonomia. Journal of neurology 257:198–206 [DOI] [PubMed] [Google Scholar]
  • 2.Barlow SM (2009) Central pattern generation involved in oral and respiratory control for feeding in the term infant. Current opinion in otolaryngology & head and neck surgery 17:187–193 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Brown WJ, Beauchemin JA, Linde LM (1964) A Neuropathological Study of Familial Dysautonomia (Riley-Day Syndrome) in Siblings. Journal of neurology, neurosurgery, and psychiatry 27:131–139 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Brunt PW, McKusick VA (1970) Familial dysautonomia. A report of genetic and clinical studies, with a review of the literature. Medicine 49:343–374 [PubMed] [Google Scholar]
  • 5.Geltzer AI, Gluck L, Talner NS, Polesky HF (1964) Familial Dysautonomia; Studies in a Newborn Infant. The New England journal of medicine 271:436–440 [DOI] [PubMed] [Google Scholar]
  • 6.Gutierrez JV, Kaufmann H, Palma JA, Mendoza-Santiesteban C, Macefield VG, Norcliffe-Kaufmann L (2017) Founder mutation in IKBKAP gene causes vestibular impairment in familial dysautonomia. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 129:390–396 [DOI] [PubMed] [Google Scholar]
  • 7.Gutierrez JV, Norcliffe-Kaufmann L, Kaufmann H (2015) Brainstem reflexes in patients with familial dysautonomia. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 126:626–633 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Halpern H, Hochberg I, Rees N (1967) Speech and hearing characteristics in familial dysautonomia. Journal of speech and hearing research 10:361–366 [DOI] [PubMed] [Google Scholar]
  • 9.Lefcort F, Mergy M, Ohlen SB, Ueki Y, George L (2017) Animal and cellular models of familial dysautonomia. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 27:235–243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Maayan C, Kaplan E, Shachar S, Peleg O, Godfrey S (1987) Incidence of familial dysautonomia in Israel 1977–1981. Clin Genet 32:106–108 [DOI] [PubMed] [Google Scholar]
  • 11.Mackie IA (1995) Neuroparalytic keratitis In: Fraunfelder F, Roy FH, Meyer SM (eds) Current Ocular Therapy. Saunders, Philadelphia, p 452–454 [Google Scholar]
  • 12.Mahloudji M, Brunt PW, McKusick VA (1970) Clinical neurological aspects of familial dysautonomia. Journal of the neurological sciences 11:383–395 [DOI] [PubMed] [Google Scholar]
  • 13.Margulies SI, Brunt PW, Donner MW, Silbiger ML (1968) Familial dysautonomia. A cineradiographic study of the swallowing mechanism. Radiology 90:107–112 [DOI] [PubMed] [Google Scholar]
  • 14.Mass E, Gadoth N (1994) Oro-dental self-mutilation in familial dysautonomia. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 23:273–276 [DOI] [PubMed] [Google Scholar]
  • 15.Mass E, Sarnat H, Ram D, Gadoth N (1992) Dental and oral findings in patients with familial dysautonomia. Oral surgery, oral medicine, and oral pathology 74:305–311 [DOI] [PubMed] [Google Scholar]
  • 16.Mendoza-Santiesteban CE, Palma JA, Norcliffe-Kaufmann L, Kaufmann H (2017) Familial dysautonomia: a disease with hidden tears. Journal of neurology 264:1290–1291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Norcliffe-Kaufmann L, Slaugenhaupt SA, Kaufmann H (2017) Familial dysautonomia: History, genotype, phenotype and translational research. Prog Neurobiol 152:131–148 [DOI] [PubMed] [Google Scholar]
  • 18.Palma JA, Norcliffe-Kaufmann L, Fuente-Mora C, Percival L, Mendoza-Santiesteban C, Kaufmann H (2014) Current treatments in familial dysautonomia. Expert opinion on pharmacotherapy 15:2653–2671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Palma JA, Spalink C, Barnes EP, Norcliffe-Kaufmann L, Kaufmann H (2018) Neurogenic dysphagia with undigested macaroni and megaesophagus in familial dysautonomia. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 28:125–126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Pearson J, Pytel B (1978) Quantitative studies of ciliary and sphenopalatine ganglia in familial dysautonomia. Journal of the neurological sciences 39:123–130 [DOI] [PubMed] [Google Scholar]
  • 21.Pearson J, Pytel BA (1978) Quantitative studies of sympathetic ganglia and spinal cord intermedio-lateral gray columns in familial dysautonomia. Journal of the neurological sciences 39:47–59 [DOI] [PubMed] [Google Scholar]
  • 22.Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP, Liebert CB, Chadwick B, Idelson M, Reznik L, Robbins C, Makalowska I, Brownstein M, Krappmann D, Scheidereit C, Maayan C, Axelrod FB, Gusella JF (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. American journal of human genetics 68:598–605 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Yousry I, Camelio S, Schmid UD, Horsfield MA, Wiesmann M, Brückmann H, Yousry TA (2000) Visualization of cranial nerves I–XII: value of 3D CISS and T2-weighted FSE sequences. European Radiology 10:1061–1067 [DOI] [PubMed] [Google Scholar]

RESOURCES